Miller M, Song M, Bessler A, Ruelas-Vargas K, Frank D, Harris SH, Gibbons JB, Jordan AE, Krawczyk, Saloner B - Addiction Science & Clinical Practice
Interviews with 16 staff from four opioid treatment programs that launched mobile methadone units found implementation was slowed by inconsistent DEA guidance, vehicle maintenance and parking requirements, workforce shortages, community opposition, and lower-than-expected patient demand. Persistent leadership, sustained state funding, and strong cross-program partnerships helped get units running, suggesting that the potential of mobile units to expand methadone access depends on these factors.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine
Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open